This is a preview of subscription content, log in via an institution to check access.
Notes
CHMP = Committee for Medicinal Products for Human Use
see Reactions 1774 p2; 803427076
Reference
Health Products Regulatory Authority. Reminder: EMA advises companies on steps to take to avoid nitrosamines in human medicines. Internet Document : 3 Dec 2019. Available from: URL: https://www.hpra.ie/homepage/medicines/news-events/item?t=/reminder-ema-advises-companies-on-steps-to-take-to-avoid-nitrosamines-in-human-medicines&id=bdb30c26-9782-6eee-9b55-ff00008c97d0
Rights and permissions
About this article
Cite this article
MAHs should review medicines for nitrosamine impurities. Reactions Weekly 1783, 5 (2019). https://doi.org/10.1007/s40278-019-72488-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-72488-3